Morgan Lewis Advises Russia-China Investment Fund on Creation of Large Russian Pharma Holding Company

MOSCOW, February 19, 2021: Morgan Lewis represented a consortium of investors led by the Russia-China Investment Fund (RCIF), which was established by the Russian Direct Investment Fund and China Investment Corporation, on the establishment and joint development of Binnopharm Group, a pharmaceutical holding company created on the basis of JSC Alium and OJSC Sintez.

As a result, Binnopharm Group will become one of the three largest pharmaceutical manufacturers in Russia.

Partner Artem Tamaev and associates Emil Shagiakhmetov, Valentina Semenikhina, Philip Korotin, Anastasia Kiseleva, and Andrey Ignatenko.

For more, read the RCIF’s announcement.